OMM, HSF act on Peijia Medical’s $302 mln HK IPO

BY Aparna Sai |

O’Melveny & Myers and Jingtian & Gongcheng have advised Chinese medical device company Peijia Medical on its HK$2.34 billion ($302 million) IPO on the Hong Kong Stock Exchange, with Herbert Smith Freehills and Commerce & Finance Law Offices representing the underwriters.

Davis Polk, Latham advise on Venus Medtech‘s $331 mln Hong Kong IPO

BY Aparna Sai |

Davis Polk and King & Wood Mallesons have represented Chinese medical device manufacturer Venus Medtech on its $331.17 million initial public offering on the Hong Kong Stock Exchange, with Latham & Watkins and Jingtian & Gongcheng advising the joint sponsors.